$1.76
10.66% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US00808Y2081
Symbol
AEMD

Aethlon Medical, Inc. Stock price

$1.76
-1.55 46.89% 1M
-1.11 38.65% 6M
-5.12 74.42% YTD
-3.74 67.98% 1Y
-111.84 98.45% 5Y
-8,938.24 99.98% 10Y
-15,598.24 99.99% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.21 10.66%
ISIN
US00808Y2081
Symbol
AEMD
Sector

Key metrics

Market capitalization $3.54m
Enterprise Value $-1.29m
EV/FCF (TTM) EV/FCF 0.15
P/B ratio (TTM) P/B ratio 5.68
Free Cash Flow (TTM) Free Cash Flow $-8.55m
Cash position $4.83m
P/E forward negative
Short interest 0.07%

Is Aethlon Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Aethlon Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Aethlon Medical, Inc. forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Aethlon Medical, Inc. forecast:

Buy
50%
Hold
50%

Financial data from Aethlon Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 12 12
7% 7%
-
- Research and Development Expense - -
-
-
-11 -11
3% 3%
-
- Depreciation and Amortization 0.35 0.35
3% 3%
-
EBIT (Operating Income) EBIT -12 -12
3% 3%
-
Net Profit -11 -11
3% 3%
-

In millions USD.

Don't miss a Thing! We will send you all news about Aethlon Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aethlon Medical, Inc. Stock News

Neutral
PRNewsWire
5 days ago
Poster Presentation Reviews the Hemopurifier ® Affinity Resin's A bility to Bind Extracellular Vesicles in Long COVID Samples SAN DIEGO , June 9, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that an abstract has been accepted for poster presentatio...
Neutral
PRNewsWire
about one month ago
Results Reinforce the Current Australian Oncology Clinical Trial and Support Investigation of the Hemopurifier Across Multiple Indications SAN DIEGO , May 14, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication ( https://www.biorxiv.org/cg...
Neutral
PRNewsWire
3 months ago
Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology Results Support Further Evaluation of the Hemopurifier ®  as Part of a Machine Perfusion Circuit to Further Assess its Impact on the Function of Retrieved Kidneys SAN DIEGO , March 10, 2025 /PRNewswire/ -- Aethlon Medical, Inc.  (Nasdaq: AEMD), a medical therapeutic company focused on deve...
More Aethlon Medical, Inc. News

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.

Head office United States
CEO James Frakes
Employees 14
Founded 1991
Website www.aethlonmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today